Mon, July 18, 2022
Sat, July 16, 2022
Fri, July 15, 2022
Thu, July 14, 2022

Thomas Shrader Initiated (ABOS) at Strong Buy and Held Target at $15 on, Jul 15th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-15-on-jul-15th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Thomas Shrader of BTIG, Initiated "Acumen Pharmaceuticals, Inc." (ABOS) at Strong Buy and Held Target at $15 on, Jul 15th, 2022.

Thomas has made no other calls on ABOS in the last 4 months.



There are 2 other peers that have a rating on ABOS. Out of the 2 peers that are also analyzing ABOS, 0 agree with Thomas's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Thomas


  • Andrew Fein of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $15 on, Thursday, June 30th, 2022
  • Judah Frommer of "Credit Suisse" Maintained at Buy with Decreased Target to $17 on, Tuesday, March 29th, 2022

Publication Contributing Sources